References
Leung DY, Soter NA: Cellular and immunologic mechanisms in atopic dermatitis. J Am Acad Dermatol 2001, 44(suppl 1):S1-S12.
Tofte SJ, Hanifin JM: Current management and therapy of atopic dermatitis. J Am Acad Dermatol 2001, 44(suppl 1):S13-S16.
Bekersky I, Fitzsimmons W, Tanase A, et al.: Nonclinical and early clinical development of tacrolimus ointment for the treatment of atopic dermatitis. J Am Acad Dermatol 2001, 44(suppl 1):S17-S27.
Hanifin JM, Ling MR, Langley R, et al.: Tacrolimus ointment for the treatment of atopic dermatitis in adult patients: part I, efficacy. J Am Acad Dermatol 2001, 44(suppl 1):S28-S38.
Soter NA, Fleischer AB Jr, Webster GF, et al.: Tacrolimus ointment for the treatment of atopic dermatitis in adult patients: part II, safety. J Am Acad Dermatol 2001, 44(suppl 1):S39-S46.
Paller A, Eichenfield LF, Leung DY, et al.: A 12-week study of tacrolimus ointment for the treatment of atopic dermatitis in pediatric patients. J Am Acad Dermatol 2001, 44(suppl 1):S47-S57.
Kang S, Lucky AW, Pariser D, et al.: Long-term safety and efficacy of tacrolimus ointment for the treatment of atopic dermatitis in children. J Am Acad Dermatol 2001, 44(suppl 1):S58-S64.
Drake L, Prendergast M, Maher R, et al.: The impact of tacrolimus ointment on health-related quality of life of adult and pediatric patients with atopic dermatitis. J Am Acad Dermatol 2001, 44(suppl 1):S65-S72.
Rights and permissions
About this article
Cite this article
Beltrani, V.S. Tacrolimus ointment: Advancing the treatment of atopic dermatitis. Curr Allergy Asthma Rep 1, 307–308 (2001). https://doi.org/10.1007/s11882-001-0040-4
Issue Date:
DOI: https://doi.org/10.1007/s11882-001-0040-4